[HTML][HTML] Newer ACE inhibitors: a look at the future
A Salvetti - Drugs, 1990 - Springer
Available information indicates that about 78 new molecules belonging to the class of
angiotensin converting enzyme (ACE) inhibitors are under investigation, and that at least 11 …
angiotensin converting enzyme (ACE) inhibitors are under investigation, and that at least 11 …
Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines
J Krapcho, C Turk, DW Cushman… - Journal of medicinal …, 1988 - ACS Publications
Analogues of captopril, enalaprilat, and the phosphinic acid [[hydroxy (4-phenylbutyl)
phosphinyl] acetyl]-L-proline incorporating 4-substituted proline derivatives have been …
phosphinyl] acetyl]-L-proline incorporating 4-substituted proline derivatives have been …
A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor.
JF Waterfall - British Journal of Clinical Pharmacology, 1989 - Wiley Online Library
1. Cilazapril is the monoethyl ester prodrug form of the di‐acid cilazaprilat, a new
angiotensin converting enzyme (ACE) inhibitor. Cilazaprilat has an IC50 of 1.9 nM as an …
angiotensin converting enzyme (ACE) inhibitor. Cilazaprilat has an IC50 of 1.9 nM as an …
Design and therapeutic potential of peptides
AS DUTTA - Advances in Drug Research, 1991 - Elsevier
Peptides and proteins are involved in controlling a large number of biological functions in
various life forms. In man, some of the peptides are released from endocrine glands into …
various life forms. In man, some of the peptides are released from endocrine glands into …
[HTML][HTML] Spirapril: a preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension
S Noble, EM Sorkin - Drugs, 1995 - Springer
Synopsis Spirapril is a non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor pro-
drug which is converted to the active metabolite spiraprilat following oral administration, and …
drug which is converted to the active metabolite spiraprilat following oral administration, and …
Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease
S Krähenbühl, P Grass, A Surve, K Kutz… - European journal of …, 1993 - Springer
The pharmacokinetics and haemodynamic effects of orally administered spirapril, a novel
angiotensinconverting enzyme (ACE) inhibitor, have been investigated in patients with liver …
angiotensinconverting enzyme (ACE) inhibitor, have been investigated in patients with liver …
Short‐and Long‐Term Effects of Spirapril on Renal Hemodynamics in Patients with Essential Hypertension
GP Reams, A Lau, V Knaus… - The Journal of Clinical …, 1993 - Wiley Online Library
Sixteen essential hypertensive patients were entered into a protocol assessing the effect of
Spirapril, an angiotensin‐converting enzyme (ACE) inhibitor, on blood pressure, the renin …
Spirapril, an angiotensin‐converting enzyme (ACE) inhibitor, on blood pressure, the renin …
Neutral endopeptidase inhibitors and combined inhibitors of neutral endopeptidase and angiotensin-converting enzyme
JA Robl, NC Trippodo, EW Petrillo - Antihypertensive Drugs, 1997 - books.google.com
Neutral endopeptidase (NEP) is an abundant, zinc-containing metalloendopeptidase which
was discovered in three converging lines of investigation during the past two decades. It was …
was discovered in three converging lines of investigation during the past two decades. It was …
[PDF][PDF] Ангиотензин-превращающий фермент. Доменная структура и свойства
ЕВ Кугаевская - Биомедицинская химия, 2005 - pbmc.ibmc.msk.ru
Ангаотензин-превращающий фермент (АПФ)-это Zn-зависимая протеиназа,
участвующая в метаболизме важнейших вазоактивных пептидов ренин …
участвующая в метаболизме важнейших вазоактивных пептидов ренин …
Antihypertensive effect of spirapril and felodipine during repeated administration to spontaneously hypertensive rats
A Monopoli, A Forlani, S Milani, E Ongini - Pharmacological research …, 1988 - Elsevier
The antihypertensive activity of spirapril given alone or in combination with felodipine was
investigated in spontaneously hypertensive rats (SHR) during a 3-week treatment regimen …
investigated in spontaneously hypertensive rats (SHR) during a 3-week treatment regimen …